RO7496353

N/A

Report date: 2024/11/15 11:29:15

Base Information

Drug NameRO7496353
Drug Alias NameRO7496353RO-7496353SOF 10RG6440RG-6440
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionTransforming growth factor beta 1 inhibitorsAntibody-dependent cell-mediated cytotoxicity (ADCC) effects
TargetsTransforming growth factor beta 1
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungStomach Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew ZealandItaly +[8] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGenentech Inc
China Registration ClassN/A

Develop Information

Active CompaniesChugai Pharmaceutical Co LtdF. Hoffmann-La Roche LtdGenentech Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungStomach Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A